Tonix Pharmaceuticals files Form 3 for Chief Commercial Officer Thomas Englese

• Chief Commercial Officer Thomas Englese filed an initial Form 3 for Tonix, reporting 694 shares held directly.
• Disclosure also listed stock options covering 59,480 shares, with exercise prices ranging from $8.05 to $20.18.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041688), on September 08, 2026, and is solely responsible for the information contained therein.